Spectral Medical Inc. (TSX: EDT)

Canada flag Canada · Delayed Price · Currency is CAD
0.520
0.00 (0.00%)
Jul 12, 2024, 1:27 PM EDT
79.31%
Market Cap 145.28M
Revenue (ttm) 1.74M
Net Income (ttm) -18.05M
Shares Out 280.38M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 450
Open 0.500
Previous Close 0.520
Day's Range n/a
52-Week Range 0.275 - 0.670
Beta 0.97
Analysts n/a
Price Target 2.00 (+284.62%)
Earnings Date Aug 8, 2024

About Spectral Medical

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrat... [Read more]

Sector Healthcare
CEO Christopher Seto
Employees 29
Stock Exchange Toronto Stock Exchange
Ticker Symbol EDT
Full Company Profile

Financial Performance

In 2023, EDT's revenue was 1.60 million, a decrease of -4.14% compared to the previous year's 1.67 million. Losses were -15.66 million, 38.6% more than in 2022.

Financial Statements

News

Spectral Medical Inc. Announces Change to Auditor

TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, t...

3 days ago - GlobeNewsWire

Spectral Medical Provides June Tigris Trial Update

TORONTO, July 02, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, t...

13 days ago - GlobeNewsWire

Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders

TORONTO, June 07, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, t...

5 weeks ago - GlobeNewsWire

Spectral Medical Inc. Announces Closing of Approximately C$8.5 Million Convertible Notes Financing

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF...

6 weeks ago - GlobeNewsWire

Spectral Medical Announces First Quarter Results and Provides Corporate Update

Tigris Trial Enrollment Reaches 106 Patients Bought Deal Financing Expected to Fund Completion of Tigris Trial Enrollment TORONTO, May 13, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or...

2 months ago - GlobeNewsWire

Spectral Medical Inc. Announces C$8.5 Million Bought Deal Convertible Note Financing

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF...

2 months ago - GlobeNewsWire

Spectral Medical Provides April Tigris Trial Update

•   105 patients enrolled •   April represents a record breaking month for patient enrollment  TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT),...

2 months ago - GlobeNewsWire

Spectral Medical Provides Tigris Trial Update

TORONTO, April 10, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, ...

3 months ago - GlobeNewsWire

Spectral Medical reports Q4 results

3 months ago - Seeking Alpha

Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update

TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, ...

3 months ago - GlobeNewsWire

Spectral Medical Provides February Tigris Trial Update

TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, t...

4 months ago - GlobeNewsWire

Spectral Medical Provides Early February Tigris Trial Update

TORONTO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, t...

5 months ago - GlobeNewsWire

Spectral Medical Provides January Tigris Trial Update

TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, t...

5 months ago - GlobeNewsWire

Spectral Medical says CFO McInnis to resign

Spectral Medical announces CFO Blair McInnis's resignation, and Chris Seto will serve as the interim CFO while the company conducts a formal search.

8 months ago - Seeking Alpha

Spectral Medical GAAP EPS of -C$0.01, revenue of C$0.4M

Spectral Medical Q3 results show a slight decrease in EPS but positive revenue growth, indicating potential stability in the financial performance.

8 months ago - Seeking Alpha

Spectral Medical Announces Third Quarter Results and Provides Corporate Update

Tigris Trial Enrollment Reaches 76 Patients Crude mortality results continue to exceed expectations TORONTO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:...

8 months ago - GlobeNewsWire

Spectral Medical Announces Second Quarter Results and Provides Corporate Update

TORONTO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, t...

1 year ago - GlobeNewsWire

Spectral Medical Announces First Quarter Results and Provides Corporate Update

New Trial Sites Enroll 60% of New Patient Enrollments Since the Beginning of April Tigris Patient Enrollment at 58 Patients TORONTO, May 12, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” ...

1 year ago - GlobeNewsWire

Spectral Medical Announces Investor Update Conference Call

TORONTO, April 06, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, ...

1 year ago - GlobeNewsWire

Spectral Medical Announces Fourth Quarter and Fiscal 2022 Results and Provides Corporate Update

Reports significant enhancements to accelerate Tigris patient enrollment including appointment of new Contract Research Organization

1 year ago - GlobeNewsWire

Spectral Announces Second Quarter Results and Provides Corporate Update

TORONTO, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, a...

3 years ago - GlobeNewsWire

Spectral Announces First Quarter Results and Provides Corporate Update

TORONTO, May 14, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as...

3 years ago - GlobeNewsWire

Spectral Announces Third Quarter Results

Dialco's DIMI receives FDA 510(k) clearance for use in hospital and clinical settings – a significant step in the full regulatory development of DIMI

3 years ago - GlobeNewsWire